Trials / Completed
CompletedNCT00746135
TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study
TRI-V Resynchronization in Paced Heart Failure Patients With ICD Indication.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
It's the aim of this study to investigate the impact of Right Ventricular (RV) lead position (RV-apex, His bundle area, RV-apex+His bundle area) in combination with individually optimized Left Ventricular (LV) lead placement and CRT timing on the outcome of cardiac resynchronization therapy (CRT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Device Implantation | RV apical pacing lead, RV pacing lead at HIS bundle position, LV pacing lead implantation |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2010-10-01
- Completion
- 2012-12-01
- First posted
- 2008-09-03
- Last updated
- 2019-02-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00746135. Inclusion in this directory is not an endorsement.